Victory Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $447K | Buy |
31,864
+19,257
| +153% | +$270K | ﹤0.01% | 2078 |
|
|
2025
Q1 | $197K | Sell |
12,607
-127
| -1% | -$1.99K | ﹤0.01% | 2223 |
|
|
2024
Q4 | $177K | Sell |
12,734
-109
| -0.8% | -$1.52K | ﹤0.01% | 2260 |
|
|
2024
Q3 | $119K | Buy |
12,843
+1,155
| +10% | +$10.7K | ﹤0.01% | 2305 |
|
|
2024
Q2 | $109K | Sell |
11,688
-487
| -4% | -$4.53K | ﹤0.01% | 2285 |
|
|
2024
Q1 | $121K | Buy |
12,175
+1,756
| +17% | +$17.4K | ﹤0.01% | 2280 |
|
|
2023
Q4 | $33.7K | Buy |
+10,419
| New | +$33.7K | ﹤0.01% | 2474 |
|
|
2022
Q4 | – | Sell |
-25,000
| Closed | -$478K | – | 2594 |
|
|
2022
Q3 | $478K | Buy |
+25,000
| New | +$478K | ﹤0.01% | 2073 |
|
|
2020
Q2 | – | Sell |
-7,720
| Closed | -$230K | – | 2552 |
|
|
2020
Q1 | $230K | Buy |
+7,720
| New | +$230K | ﹤0.01% | 2297 |
|